PALMA DE MALLORCA,Spain,March 5,2025-- LaminarPharma,a leader in the development of innovative cancer therapy based on membrane lipid therapy,announced today optimistic results from its ongoing clini
03-06
CHIȘINĂU,Moldova,March 3,2025--The e-Governance Agency of Moldova (AGE) is proud to announce its participation in the second round of Large-Scale Pilot Projects (LSP) for the EU Digital Identity Wal
03-05
- EffiX™ is designed to meet the industry\'s demand for a high-yield,stable,and non-lysogenic E. coli expression system. It serves as a comprehensive solution for the development and manufacturing of
03-05
BARCELONA,Spain and ISTANBUL,March 4,2025-- TECNO,an AI-driven technology brand,is teaming up with Koç University in Türkiye,a leading research university located at the intersection of E
03-05
MELBOURNE,Australia and INDIANAPOLIS,Ind.,March 4,2025-- Telix Pharmaceuticals Limited (ASX: TLX,Nasdaq: TLX,Telix,the Company) invites investors to join a webinar showcasing the Company\'s late-stag
03-05
Industrial specialist to centralise document management and automate processes AUCKLAND,New Zealand,March 4,2025-- Property for Industry (PFI),a specialist in the industrial sector,has extended its p
03-05
STOCKHOLM,March 4,2025-- RaySearch Laboratories AB (publ) is pleased to announce that Heyou Hospital,located in Foshan City,Guangdong Province,China,has placed an order for the treatment planning syst
03-05
BEIJING,March 4,2025--A report from People\'s Daily: Lately,there has been much talk about foreign investors withdrawing from China on a large scale. Official data show that in 2024,foreign direct inv
03-05
INDIANAPOLIS,March 4,2025--The Indianapolis Prize,the world\'s leading award for animal conservation,has named Mwezi "Badru" Mugerwa the Winner of the 2025 Indianapolis Prize Emerging Conse
03-05
BARCELONA,Spain,March 4,2025-- LITEON Technology participates in the 2025 Mobile World Congress in Barcelona,for the third consecutive year. Under the theme "One Partner. All Solutions," LIT
03-05
The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange
Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement
MEXC Claims Dual Wins at BeInCrypto 100 Awards as Best Centralized Exchange and Best Exchange in LATAM
©copyright 2009-2020 Singapore Info Map
